Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19

ClinicalTrials.gov ID: NCT04966013

Public ClinicalTrials.gov record NCT04966013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 10:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Sham Controlled Dose Finding Study of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, sham controlled, dose finding study of the EmitBio RD-X19 device in individuals with symptomatic COVID-19 in the outpatient setting.

Study identification

NCT ID
NCT04966013
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
EmitBio Inc.
Industry
Enrollment
216 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 17, 2021 (Actual)
Primary completion
Jan 5, 2022 (Actual)
Completion
Feb 23, 2022 (Actual)
Last update posted
Sep 19, 2024

2021 – 2022

United States locations

U.S. sites
9
U.S. states
5
U.S. cities
9
Facility City State ZIP Site status
Site 2 - Innovative Research of West Florida, Inc. Clearwater Florida 33756 —
Site 1 - APF Research LLC Miami Florida 33134 —
Site 8 - WellNow Urgent Care Kalamazoo Michigan 49048 —
Site 9 - Revival Research Institute, LLC Sterling Heights Michigan 48312 —
Site 4 - Peters Medical Research High Point North Carolina 27260 —
Site 7 - WellNow Urgent Care Cincinnati Ohio 45215 —
Site 5 - WellNow Urgent Care Columbus Ohio 43214 —
Site 6 - WellNow Urgent Care Dayton Ohio 45424 —
Site 3 - J&S Studies, Inc. College Station Texas 77845 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04966013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 19, 2024 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04966013 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →